Radioiodine treatment of differentiated thyroid cancer despite history of ‘iodine allergy’

Abstract

SummaryRadioiodine (131I) is a critical component in the treatment of differentiated thyroid cancer. We recently saw a patient with thyroid cancer who was hesitant to take 131I treatment because he had previously encountered an allergic reaction to administration of iodine-containing radiocontrast agent for computed tomography (CT) scanning. We were able to administer 131I treatment after discussion that his anaphylactic reaction was not due to iodine and that radioiodine (131I) treatment is unlikely to cause a reaction in the patient.Learning points An allergy to iodine itself does not exist.When patients claim that they have an ‘iodine allergy’, ask them what substances they are allergic to and what kind of reaction occurred during use of such substances.Radioactive iodine is not a contraindication for patients who claim an ‘allergy to iodine’.

A Modality in the Diagnosis and Treatment of Oral Candidiasis

“…Many published studies show that Lugol's has many benefits in developing the immune system, hormone balance, and alleviating symptoms in HIV/ AIDS patients in Africa. [8,9] Based on the literature, though few in number, the references indicate Lugol's application, the 2% iodine solution as a candidate for the treatment of candidiasis previously detected with blue methylene in the patients involved in the studies referred in the literature. Iodine delivery in patients is progressively carried out, ranging from 1 dropper day, 2.5 mg, to a maximum of 5 drops/day, 12.5 mg, proportionally divided by day.…”

“…[5] Patients involved in study, declare for lack of iodine allergies, and during subtype in this therapy, were kept under control for systemic sensations previously unpublished but based on literature, as sleeping disturbances, worries in the nutritional constituents of the individual diet, or any other concern. [9,10]…”